Manon Benabides
Corbeil-essonnes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation.
Journal: JCI insight
Published: September 09, 2025
Galectin-3: a novel biomarker of glycogen storage disease type III.
Journal: Cell death discovery
Published: October 11, 2024
High-throughput screening identifies bazedoxifene as a potential therapeutic for dysferlin-deficient limb girdle muscular dystrophy.
Journal: British journal of pharmacology
Published: April 19, 2024
Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells.
Journal: Frontiers in cell and developmental biology
Published: February 10, 2023
Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination.
Journal: Frontiers in pharmacology
Published: January 17, 2022
The Future of Regenerative Medicine: Cell Therapy Using Pluripotent Stem Cells and Acellular Therapies Based on Extracellular Vesicles.
Journal: Cells
Published: November 30, 2020
Identification of thiostrepton as a pharmacological approach to rescue misfolded alpha-sarcoglycan mutant proteins from degradation.
Journal: Scientific reports
Published: October 19, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026